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1  | INTRODUC TION
The risk of death varies among patients with ST‐elevation myocar‐
dial infarction (STEMI). Specific risk scores have been developed 
to improve risk assessment. The TIMI (thrombolysis in myocardial 
infarction) risk score applies clinical data to assess the risk of death 
(Morrow et al., 2000). ECG‐based risk scores were introduced to 
aid in the assessment of acuteness of the ischemic process (Wilkins 
et al., 1995) and the area at risk (Aldrich et al., 1988). However, 
the presenting ECG in STEMI provides prognostic tools without 
need for complex analyses. The Sclarovsky‐Birnbaum grading of 
ischemia classifies STEMI patients into two categories according to 
the distortion of the terminal portion of the QRS complex: grade 3 
ischemia predicts higher short‐ and mid‐term mortality and a larger 
infarct with a higher thrombus burden and more microvascular 
damage (Birnbaum, Birnbaum, & Birnbaum, 2014). However, this 
score applies only to patients with positive T waves in the leads 
with ST elevation. Another “at‐a‐glance” classification of STEMI is 
simply based on the analysis of Q and T waves in the ECG at presen‐
tation. “Evolving myocardial infarction” (EMI) is defined as patho‐
logical Q waves and/or inverted T waves, while these changes are 
absent in the “Pre‐infarction syndrome” (PIS) (Sclarovsky, 1999). In 
the DANAMI‐2 trial, patients with PIS had more advantage of pri‐
mary percutaneous coronary intervention (pPCI) than of fibrinolytic 
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Abstract
Background: Both Q waves and T‐wave inversion (TWI) in the presenting ECG are 
associated with a progressed stage of myocardial infarction, possibly with less poten‐
tial for myocardial salvage with reperfusion therapy. Combining the diagnostic infor‐
mation from the Q‐ and T‐wave analyses could improve the prognostic work‐up in 
ST‐elevation myocardial infarction (STEMI) patients.
Methods: We sought to determine the prognostic impact of Q waves and TWI in the 
admission ECG on patient outcome in STEMI. We formed four groups according to 
the	presence	of	Q	waves	and/or	TWI	 (Q+TWI+;	Q−TWI+;	Q+TWI−;	Q−TWI−).	We	
studied 627 all‐comers with STEMI derived from two patient cohorts.
Results:	The	patients	with	Q+TWI+	had	the	highest	and	those	with	Q−TWI−	the	low‐
est	30‐day	and	one‐year	mortality.	One‐year	mortality	was	similar	between	Q−TWI+	
and	Q+TWI−.	The	survival	analysis	showed	higher	early	mortality	in	Q+TWI−	but	the	
higher	late	mortality	in	Q−TWI+	compensated	for	the	difference	at	1	year.	The	high‐
est	peak	troponin	level	was	found	in	the	patients	with	Q+TWI−.
Conclusion: Q waves and TWI predict adverse outcome, especially if both ECG fea‐
tures are present. Q waves and TWI predict similar one‐year mortality. Extending the 
ECG analysis in STEMI patients to include both Q waves and TWI improves risk 
stratification.
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therapy (FT), while in the patients presenting with the EMI pattern, 
there was no significant difference between the two therapies 
(Eskola et al., 2007). The prognostic role of Q waves and T‐wave in‐
versions (TWI) in acute MI has been separately investigated in sev‐
eral studies. Q waves are the hallmark of myocardial necrosis, but 
they may also represent reperfusion (Blumenthal, Wang, & Pang, 
1975; Horan, Flowers, & Johnson, 1971; Savage, Wagner, Ideker, 
Podolsky, & Hackel, 1977). Q waves predicted nonpatency of the 
culprit artery (Wong et al., 1999), a larger infarct (Delewi et al., 
2013; Raitt et al., 1995) and higher 30‐day and one‐year mortality 
(Birnbaum et al., 1997; Siha et al., 2012; Wong et al., 2006). Post‐
treatment TWI in STEMI was associated with culprit artery patency 
and a favorable outcome (Corbalan et al., 1999; Doevendans et al., 
1995; Lee et al., 2017; Matetzky et al., 1994; Ophuis et al., 2000; 
Sgarbossa et al., 2000), possibly indicating myocardial reperfusion. 
However, inverted T waves in the presenting ECG have been asso‐
ciated both with patency (Hira, Moore, Huang, Wilson, & Birnbaum, 
2014) and nonpatency (Wong et al., 1999) of the culprit artery. 
Combining the diagnostic information from the Q‐ and T‐wave 
analyses could improve the prognostic work‐up in STEMI patients. 
Accordingly, the aim of this study was to establish the prognostic 
role of Q waves and TWIs in a real‐life STEMI population.
2  | METHODS
This study comprises two Finnish nonrandomized STEMI popula‐
tions. The STEMI 2005 study was conducted in the region of the 
Tampere University Hospital with a population of ~1.2 M. Data on 
the incidence, demographics, treatment strategies and delays were 
collected for consecutive STEMI patients (n = 310) in four hospital 
districts during a six‐month period (Nikus et al., 2008). Regarding 
reperfusion therapy, both pPCI and FT were used. The study was 
observational, and treatment choices were based on prevailing in‐
ternational and regional guidelines.
In the HUS‐STEMI study, patients (n = 448) were included 
during one year (2007–2008) in the district of the Helsinki 
University Central Hospital (Viikila et al., 2013). The study was ob‐
servational, and the choice of reperfusion therapy was based on 
the decision by a consulting cardiologist. FT was recommended 
for hemodynamically stable patients when the time from symptom 
onset	to	treatment	was	≤3	hr.	As	in	the	STEMI	2005	study,	use	of	
ancillary anti‐thrombotic therapy and other therapeutic decisions 
were based on prevailing guidelines.
There were no prespecified exclusion criteria in the two studies. 
The inclusion criteria were as follows:
Acute chest pain/discomfort and
1. ST‐elevations	 of	 ≥0.2	mV	 in	 at	 least	 2	 of	 the	 leads	 V1–3	 or
2. ST‐elevations	of	≥0.1	mV	in	at	least	2	other	contiguous	leads	(V4–
6; I, aVL; II, III, aVF) or
3. New or presumably new left bundle branch block.
We used troponin T with a cutoff <0.01 μg/L. Renal insufficiency 
was defined as creatinine >150 μM (1.70 mg/dl) on admission.
A written informed consent was signed by the patients before en‐
rolment. The local Ethics Committees approved the study protocol.
For the present study, mortality data were collected from the 
official national registry (Statistics Finland), which records 100% 
of deaths of Finnish citizens at home and nearly 100% abroad. 
Regarding other endpoints, data from the two studies were used.
The primary endpoint was mortality at one year. Other prespec‐
ified endpoints were in‐hospital mortality, 30‐day mortality, and 
30‐day MACE (major adverse cardiovascular events: a composite of 
cardiovascular death, stroke, re‐infarction and new, unplanned re‐
vascularization procedures).
The definition of “no revascularization therapy” (NRT) was: no FT 
or angiography within 4 hr from presentation.
The ECG data were analyzed by one investigator (KK), who at 
the time of the analysis was blinded to clinical data. In case of doubt, 
a mutual agreement was sought with two senior cardiologists (ME, 
KN). We found that in 46 patients the ST changes did not meet the 
established cutoff values, although included by the investigators 
on‐site. These patients were excluded. Likewise, patients with a 
missing/incomplete (n = 25), or noninterpretable ECG (n = 8) were 
excluded. Patients with a wide QRS (>120 ms) were excluded as well 
(n = 52) (Figure 1).
Pathological Q waves were defined according to the Third 
Universal Definition of Myocardial Infarction (Thygesen et al., 2012). 
Any	TWI	≥0.05	mV	was	considered	as	inverted.	Q	waves	and	TWIs	
outside the leads with maximum ST elevation were ignored. We 
formed four groups according to the presence of Q waves and/or 
TWIs	(Q+TWI+,	Q−TWI+,	Q+TWI−,	and	Q−TWI−)	(Figure	2).
The data were analyzed with SPSS Statistics 25. We compared 
the four groups with respect to different prespecified variables. 
In categorical variables, we used the χ2 test or when applicable, 
Fisher’s exact test. The distribution of all continuous variables was 
skewed, so we used median values and the independent‐samples 
Mann–Whitney U test for the difference between the two groups. 
Interquartile ranges were defined using the weighted average. We 
performed a logistic regression univariate analysis using one‐year 
mortality as the endpoint. We present odds ratios with 95% confi‐
dence intervals (CI). We selected the variables with a p value <0.1 to 
the multivariable analysis.
3  | RESULTS
The	Q+TWI+	pattern	was	 found	 in	29	patients	 (4.6%),	Q−TWI+	 in	
50	patients	(8.0%),	Q+TWI−	in	130	patients	(20.7%)	and	Q−TWI−	in	
418 patients (66.7%) (Figure 1). The distribution of the four groups 
was similar in the STEMI 2005 and HUS‐STEMI studies (p = 0.304).
The baseline characteristics of the four ECG categories are 
shown in Table 1. The Q+TWI+ group clearly had the highest pro‐
portion of males (82.8%), as the proportion in the other three groups 
was 44.0%–67.7% (p = 0.003). The proportion of patients with 
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diabetes	 was	 highest	 in	 Q+TWI+	 (34.5%)	 and	 lowest	 in	 Q−TWI−	
(15.6%), p = 0.033. Killip class >1 was seen more often in the groups 
with	Q	waves	(44.8%	in	Q+TWI+	and	39.5%	in	Q+TWI−)	as	compared	
to	those	with	no	Q	waves	(30.0%	in	Q−TWI+	and	23.8%	in	Q−TWI−),	
p = 0.001. Likewise the location of the STEMI more often was ante‐
rior in the groups with Q waves (p < 0.001) with the highest propor‐
tion	in	the	Q+TWI−	group	(76.9%).
There was no significant difference between the groups in the 
rate of pPCI. However, FT more often was given to the patients with 
no	TWI	(55.4%	in	Q+TWI−	and	58.4%	in	Q−TWI−)	as	compared	to	
those	with	TWI	(24.1%	in	Q+TWI+	and	28.0%	in	Q−TWI+),	p < 0.001. 
Also, the proportion of patients who received no immediate reperfu‐
sion therapy differed between the groups being highest in Q+TWI+ 
(34.5%)	and	lowest	in	Q−TWI−	(8.4%),	p < 0.001. There was no sig‐
nificant difference in the use of medication between the groups.
Time from symptom onset to ECG was longest in the patients 
with	TWI	(365	min	in	Q+TWI+	and	184	min	in	Q−TWI+)	and	shortest	
in	 those	with	no	TWI	 (89	min	 in	Q+TWI−	and	73	min	 in	Q−TWI−),	
p < 0.001. The time from symptom onset to treatment was 498, 320, 
153, and 142 min in the respective groups, p < 0.001.
Patient outcome according to the ECG categories is shown in 
Table 2. Thirty‐day mortality was highest in patients with Q+TWI+, 
followed	 by	 Q+TWI−,	 Q−TWI−,	 and	 finally	 Q−TWI+	 (20%,	 14.4%,	
6.8% and 6.4%, respectively, p = 0.012). One‐year mortality was 
31%, 19.2%, 9.8%, and 22% in the respective groups (p < 0.001). 
One‐year	 mortality	 did	 not	 differ	 between	 the	 Q+TWI−	 and	 Q−
TWI+ patients (p = 0.677, not shown in the tables).
The highest peak troponin levels were found in patients with 
Q+TWI−	 (3.23	μg/L), followed by Q+TWI+ (2.81 μg/L),	 Q−TWI+	
(2.59 μg/L)	and	Q−TWI−	(1.81	μg/L), p value for the difference was 
0.002. In the Kaplan–Meier survival analysis, the patients with 
Q+TWI+ had the worst outcome early‐on (Figure 3). Patients with 
Q+TWI−	and	those	with	Q−TWI+	had	similar	one‐year	survival.	The	
survival curves indicate high early mortality in the former group 
while in the latter group late mortality was higher. p Value for the dif‐
ference in survival between the four groups was <0.001 (Log‐Rank).
The results of the logistic regression analyses are shown in 
Table 3. In the logistic regression univariate analysis, all other groups 
were	associated	with	higher	one‐year	mortality	as	compared	to	Q−
TWI−.	 In	 the	 multivariable	 analysis,	 Q+TWI+	 was	 independently	
associated with one‐year mortality (OR 7.14, 95%CI 2.05–24.9, 
p	=	0.002),	 while	 Q+TWI−	 was	 not	 (OR	 1.46,	 95%CI	 0.614–3.54,	
p	=	0.385),	 and	 Q−TWI+	 had	 a	 tendency	 toward	 independent	 as‐
sociation (OR 3.13, 95%CI 0.900–10.9, p = 0.073). Other variables 
independently associated with one‐year mortality were age, hyper‐
lipidemia, and Killip class >1.
4  | DISCUSSION
Q waves and inverted T waves have been recognized as ECG mark‐
ers of a progressed stage of myocardial infarction since the dawn of 
STEMI diagnostics. The prognosis of the combination of Q waves 
and/or TWI (evolving myocardial infarction, EMI) was studied in the 
DANAMI‐2 trial, where this ECG pattern was an independent risk 
factor for the composite endpoint of mortality, clinical infarction, 
and disabling stroke (Eskola et al., 2007). The present study is the 
first one to compare the prognosis of Q waves and TWI.
In the present study, Q waves and TWI showed different prog‐
nostic features. The patients with both Q waves and TWI had the 
worst outcome. One‐year mortality was similar in patients with ei‐
ther	Q+TWI−	or	Q−TWI+.	Interestingly,	the	Kaplan–Meier	analysis	
F I G U R E  1   The number of included 
and excluded patients and the number of 
patients in the four ECG groups
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showed	high	early	mortality	in	Q+TWI−	and	high	late	mortality	in	
Q‐TWI+. According to peak troponin values, patients with Q waves 
had larger infarcts, which could explain high early mortality. The 
relatively	high	late	mortality	of	the	Q−TWI+	group	is	more	difficult	
to explain.
The immediate ECG changes caused by acute coronary artery 
occlusion are a positive, prominent T wave and ST elevation, fea‐
tures	which	qualify	for	the	Q−TWI−	classification	 (or	preinfarction	
syndrome) (Nikus et al., 2010). Q waves and inverted T waves are 
mostly considered as later changes during the infarct process with 
less potential for myocardial salvage. However, our results imply 
that Q waves and TWI are different phenomena despite compara‐
ble outcome at one‐year follow‐up. Basically, TWI is seen in late‐
presenting STEMI patients, whereas Q waves imply a large infarct. 
Killip class was higher in patients with Q waves. As Q waves indicate 
more extensive myocardial damage, their association with higher 
Killip class is logical. Thus, a patient with both Q waves and TWI 
may often be a late‐presenter with a large infarct. It is plausible that 
F I G U R E  2   The four ECG groups showed in anterior STEMI (50 mm/s)
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this combination represents the STEMI category with the worst out‐
come in our classification.
In the present study, the proportion of anterior STEMI differed 
between the four ECG categories being highest in the patients with Q 
waves. Both Q waves (Wong et al., 2006) and inverted T waves (Hira 
et al., 2014) have been reported more often in the anterior leads. A 
high proportion of anterior STEMI in the EMI group was also reported 
in the DANAMI‐2 trial (Eskola et al., 2007). There is no evidence for 
myocardial necrosis to develop faster in the anterior wall. We think 
that the criteria are more sensitive for anterior Q waves, and this also 
is possibly true for TWI. There may also be other differences in the 
typical evolving ECG patterns in STEMI of different locations.
In individual patients, myocardial necrosis progresses at differ‐
ent rates. Collateral flow and ischemic preconditioning are known 
to alleviate the ischemic damage (Ottani et al., 1995). Hence, the 
time from symptom onset may not be the best way to assess the 
evolution of the infarct process; ECG scoring systems, such as the 
Anderson‐Wilkins score, may provide more accurate information 
(Sejersten et al., 2007).
The pathophysiologic role of Q waves in STEMI is controversial. 
In canine experiments, Q waves appeared only after the release 
of the coronary occlusion and seemed to indicate both myocardial 
reperfusion and damage (Blumenthal et al., 1975; Bodenheimer, 
Banka, Levites, & Helfant, 1976). Wong et al found Q waves to be 
TA B L E  1   Baseline characteristics
Q+TWI+ 
n = 29 
n (%)
Q−TWI+ 
n = 50 
n (%)
Q+TWI− 
n = 130 
n (%)
Q−TWI− 
n = 418 
n (%) p Value
Gender (male) 24 (82.8) 22 (44.0) 88 (67.7) 273 (65.3) 0.003
Current smoker 14 (51.9) 13 (28.3) 44 (37.6) 148 (37.0) 0.254
Diabetes 10 (34.5) 10 (20.0) 29 (22.3) 65 (15.6) 0.033
Hyperlipidemia 11 (37.9) 15 (30.0) 64 (49.2) 188 (45.0) 0.113
Hypertension 16 (57.1) 22 (44.0) 79 (60.8) 223 (53.3) 0.206
Prior STEMI 5 (17.2) 3 (6.0) 18 (14.1) 35 (8.4) 0.093
Prior angina 10 (35.7) 14 (31.8) 30 (25.2) 115 (28.5) 0.663
Prior CHF 2 (7.1) 4 (8.0) 6 (4.6) 20 (4.8) 0.591
Prior TIA/stroke 2 (6.9) 4 (8.0) 7 (5.4) 32 (7.7) 0.846
Renal insufficiency 2 (6.9) 2 (4.0) 3 (2.3) 11 (2.6) 0.387
Prior PCI 1 (3.4) 5 (10.0) 9 (6.9) 22 (5.3) 0.461
Prior CABG 2 (6.9) 2 (4.0) 2 (1.5) 12 (2.9) 0.264
Killip class >1 13 (44.8) 15 (30.0) 51 (39.5) 99 (23.8) 0.001
STEMI in anterior location 16 (55.2) 23 (46.0) 100 (76.9) 150 (35.9) <0.001
pPCI 12 (41.4) 24 (48.0) 41 (31.5) 139 (33.3) 0.143
FT 7 (24.1) 14 (28.0) 72 (55.4) 244 (58.4) <0.001
NRT 10 (34.5) 12 (24.0) 17 (13.1) 35 (8.4) <0.001
Aspirin 11 (37.9) 13 (26.0) 45 (34.6) 105 (25.2) 0.112
Clopidogrel 1 (3.4) 1 (2.0) 2 (1.5) 3 (0.7) 0.188
Warfarin 0 (0.0) 3 (6.0) 5 (3.8) 23 (5.5) 0.625
β‐blocker 7 (24.1) 19 (38.0) 45 (34.9) 122 (29.3) 0.356
Calcium channel blocker 3 (10.3) 11 (22.0) 22 (16.9) 66 (15.8) 0.578
Statin 9 (31.0) 7 (14.0) 27 (20.8) 79 (18.9) 0.301
ACEi/ARB 11 (37.9) 15 (30.0) 35 (26.9) 93 (22.4) 0.172
Median (quartiles) Median (quartiles) Median (quartiles) Median (quartiles)
Age (years) 65 (54–72) 68 (58–77) 65 (55–78) 66 (57–76) 0.831
Time from symptom onset to 
ECG (min)
356 (80–730) 184 (72–465) 89 (45–208) 73 (40–161) <0.001
Time from symptom onset to 
treatment (min)
498 (285–940) 320 (235–795) 153 (94–299) 142 (85–240) <0.001
Note. ACEi: angiotensin‐converting‐enzyme inhibitor; ARB: angiotensin receptor blocker; CABG: coronary artery bypass graft; CHF: congestive heart 
failure; FT: fibrinolytic therapy; NRT: no reperfusion therapy; PCI: percutaneous coronary intervention; pPCI: primary PCI; STEMI: ST‐elevation myo‐
cardial infarction; TIA: transient ischemic attack.
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associated with nonpatency of the infarct‐related artery (Wong et 
al., 1999). In the study of Raitt et al, abnormal Q waves were seen 
in 53% of the patients presenting within 1 hr from symptom onset, 
which makes their association with myocardial necrosis question‐
able, although Q waves did predict larger final infarct size (Raitt et 
al., 1995). Q waves may be associated with a larger area at risk. In 
cardiac magnetic resonance imaging, Q waves were a better indica‐
tor of infarct size than of infarct transmurality (Moon et al., 2004). 
Baseline Q waves have been shown to predict slower ST resolution 
even when the culprit artery is patent and the patients presents 
early, perhaps reflecting microvascular damage (Wong et al., 2002). 
Logically, higher mortality with Q waves has been reported in pa‐
tients treated with FT (Wong et al., 2006) or primary PCI (Siha et al., 
2012). Like previous studies, our study showed larger infarcts in the 
patients with Q waves.
Also the issue of inverted T waves in the ECG in STEMI is 
somewhat controversial. In patients presenting with ST eleva‐
tions, development of negative T waves (or terminally inverted 
T waves) post‐treatment is undoubtedly a predictor of favorable 
outcome, indicating culprit artery patency and reduced short‐
term mortality in patients treated with FT (Corbalan et al., 1999; 
Doevendans et al., 1995; Matetzky et al., 1994; Ophuis et al., 
2000; Sgarbossa et al., 2000) or primary PCI (Lee et al., 2017). 
The role of TWI in the presenting ECG in STEMI is less obvious. 
In STEMI patients treated with pPCI, better myocardial recov‐
ery was reported with inverted T waves (Sorensen et al., 2009). 
In the HERO‐1 study, inverted T waves in the presenting ECG 
were associated with nonpatency of the culprit artery (Wong et 
al., 1999). Contradictory, in the study by Hira et al., TWI in the 
presenting ECG predicted infarct‐related artery patency with a 
median delay from symptom onset of 5 hr. Alsaab et al., (2014 
also found an association between inverted T waves and culprit 
artery patency in a study with very short time delays: 50% of the 
patients with TWI had PCI within 1 hr from the symptom onset. 
In these studies, mortality was not assessed. In the study of Herz 
et al, TWI in the presenting ECG was a predictor of worse out‐
come in the late‐presenting (>2 hr) patients, while in the early 
presenters, there was a tendency toward favorable outcome 
(Herz et al., 1999). Shimada, Po, Kanei, and Schweitzer (2013) 
found more in‐hospital major adverse cardiac events, longer hos‐
pital stay and less ST resolution after PCI in patients with TWI. 
Although the mean delay to treatment was very long (28 hr) in 
TA B L E  2   Outcome with respect to Q waves and T‐wave inversion (for abbreviations, see Table 1)
All 
n (%) 
n = 627
Q+TWI+ 
n (%) 
n = 29
Q−TWI+ 
n (%) 
n = 50
Q+TWI− 
n (%) 
n = 130
Q−TWI− 
n (%) 
n = 418 p Value
Thirty‐day follow‐up
Thirty‐day CV mortality 47 (7.9) 4 (16.0) 3 (6.4) 14 (11.2) 26 (6.5) 0.126
Thirty‐day AMI 29 (4.9) 2 (8.0) 2 (4.3) 7 (5.6) 18 (4.5) 0.705
Thirty‐day stroke 11 (1.8) 0 (0) 0 (0) 4 (3.2) 7 (1.8) 0.655
Thirty‐day new nonelective 
CABG/PCI
15 (2.5) 0 (0) 0 (0) 2 (1.6) 13 (3.3) 0.578
Thirty‐day MACE 90 (15.1) 6 (24.0) 4 (8.5) 25 (20.0) 55 (13.8) 0.108
Lost for follow‐up 31 4 3 5 19
In‐hospital mortality 45 (7.2) 5 (17.2) 4 (8.0) 12 (9.2) 24 (5.7) 0.077
1‐year mortality 86 (13.7) 9 (31.0) 11 (22.0) 25 (19.2) 41 (9.8) <0.001
All 
Median 
(quartiles)
Q+TWI+ 
Median 
(quartiles)
Q−TWI+ 
Median 
(quartiles)
Q+TWI− 
Median 
(quartiles)
Q−TWI− 
Median 
(quartiles) p Value
Maximum troponin μg/L 2.17 
(0.588–5.38)
2.81 (1.31–4.59) 2.59 
(0.750–4.78)
3.23 
(0.930–8.80)
1.81 
(0.425–4.67)
0.002
F I G U R E  3   The Kaplan–Meier analysis showing the survival of 
patients	with	Q−TWI−,	Q+TWI−,	Q−TWI+,	and	Q+TWI+	in	one‐year	
follow‐up
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the patients with TWI, the results were similar in the patients 
presenting early (<2 hr).
It seems that TWIs in the presenting ECG and those developing 
post‐treatment have different outcome. In the presenting ECG, TWI 
indicates a later stage of the infarct with worse outcome—at least in the 
late‐presenting patients. TWI post‐treatment is a sign of reperfusion 
associated with favorable outcome. The present study parallels with 
former studies in showing higher mortality in STEMI patients with in‐
verted T waves. In the present study, most of the TWI+ patients were 
late‐presenters as defined in the study by Herz et al. (1999; median time 
from symptom onset to treatment 320–498 min in the TWI+ groups).
5  | LIMITATIONS
The study consisted of two study populations, which could result in 
nonuniformity. However, the design and the case report forms of the 
two studies were almost identical and the distribution of the studied 
ECG categories was similar in the two studies. Hence, these differ‐
ences should not represent major obstacles regarding the interpre‐
tation of the study results.
At the time of the studies, some hospitals used troponin I instead 
of troponin T. Due to this fact, we had to exclude some (n = 49) pa‐
tients from the analysis, which included troponin.
TA B L E  3   Logistic regression univariate and multivariable analyses with one‐year mortality as the endpoint
Univariate analysis Multivariable analysis
OR 95% CI p Value OR 95% CI p value
ECG
Q−TWI− Ref. Ref.
Q+TWI− 2.19 1.27–3.77 0.005 1.46 0.614–3.54 0.385
Q−TWI+ 2.59 1.23–5.45 0.012 3.13 0.900–10.9 0.073
Q+TWI+ 4.14 1.77–9.68 0.001 7.14 2.05–24.9 0.002
Male 0.436 0.275–0.690 <0.001 1.72 0.782–3.765 0.179
Age 1.10 1.07–1.13 <0.001 1.06 1.02–1.10 0.001
Current smoker 0.495 0.265–0.924 0.027 1.07 0.442–2.59 0.881
Diabetes 2.65 1.59–4.40 <0.001 1.56 0.687–3.53 0.289
Hyperlipidemia 0.497 0.304–0.811 0.005 0.413 0.183–0.930 0.033
Hypertension 1.895 1.17–3.07 0.009 2.03 0.756–5.43 0.160
Prior STEMI 1.65 0.837–3.24 0.149
Prior angina 1.94 1.14–3.29 0.014 1.24 0.603–2.54 0.561
Prior CHF 8.62 4.12–18.0 <0.001 1.43 0.402–5.07 0.582
Prior TIA/stroke 3.20 1.62–6.30 <0.001 1.66 0.549–5.00 0.370
Renal insufficiency 11.2 4.21–29.8 <0.001 1.79 0.316–10.1 0.512
Prior PCI 0.982 0.372–2.59 0.971
Prior CABG 2.51 0.871–7.22 0.088 1.86 0.288–12.1 0.514
Killip class >1 10.8 6.39–18.3 <0.001 5.99 2.83–12.1 <0.001
Time from symptom onset to ECG 1.00 0.999–1.00 0.911
Time from symptom onset to 
treatment
1.00 0.999–1.00 0.887
STEMI in anterior location 1.41 0.894–2.22 0.14
NRT Ref. Ref.
FT 0.374 0.204–0.687 0.002 1.39 0.449–4.31 0.567
pPCI 0.353 0.182–0.684 0.002 1.25 0.397–3.92 0.705
Aspirin 2.35 1.47–3.76 <0.001 1.63 0.714–3.70 0.247
Clopidogrel 2.55 0.487–13.4 0.267
Warfarin 2.31 0.998–5.35 0.050 1.24 0.284–5.44 0.772
β‐blocker 3.24 2.02–5.18 <0.001 1.57 0.704–3.48 0.272
Calcium channel blocker 2.17 1.27–3.70 0.005 1.23 0.504–3.01 0.648
Statin 1.02 0.577–1.81 0.938
ACEi/ARB 1.64 1.00–2.70 0.050 0.521 0.218–1.24 0.141
Note. For abbreviations, see Table 1.
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6  | CONCLUSION
Simply classifying STEMI patients into four categories based on Q‐ 
and T‐wave analyses aids in outcome prediction. In all‐comers, both 
Q waves and TWI predicted higher one‐year mortality than ST ele‐
vations only. Q waves were associated with larger infarcts and TWIs 
with longer treatment delays. The patients with both Q waves and 
TWI had highest one‐year mortality. Future studies in different pa‐
tient populations and treatment strategies are required to better es‐
tablish the role of this ECG classification in clinical routine practice.
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